Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ilumed

Explore full profile

Helping other healthcare organizations transition to value-based care models

Jupiter, United StatesFounded 2018Health Tech & Medtech
Valuation $50–100M Last recorded · 2021
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ilumed and the history behind them.

About ilumed

Based in Jupiter, Florida, ilumed operates as a Medicare transformation company, established in 2018 to navigate the shift towards value-based healthcare. The company was founded by CEO Debra Finnel, a healthcare industry veteran with four decades of experience in managed care and MSO leadership, who identified an opportunity to improve care delivery for the senior population. ilumed functions as an Accountable Care Organization (ACO) within the federal ACO REACH (Realizing Equity, Access, and Community Health) model, which evolved from the Direct Contracting program. This model financially incentivizes healthcare providers for delivering high-quality, cost-effective care to traditional Medicare beneficiaries.

The company's business model centers on creating partnerships with a range of healthcare providers—from solo practitioners to large health systems—to manage the complexities of value-based arrangements. Ilumed provides its partners with the necessary tools, technology, and support to succeed under a shared savings model, where providers can earn revenue above the standard Medicare fee schedule by meeting specific quality and cost targets. This approach aims to create financial stability for physicians while improving patient outcomes. For its services, ilumed has secured significant funding, including a $16.5 million Series A round in December 2021, led by Ascend Partners, and a subsequent $20 million debt financing in May 2024, bringing its total raised capital to over $86 million.

Ilumed’s core service offering revolves around its proprietary data analytics platform, BrainStream, which provides a comprehensive health profile of each patient by aggregating medical history, lab results, and prescriptions. This technology enables providers to identify at-risk patients, manage population health, and prevent costly hospital admissions by addressing potential issues proactively. Beyond technology, ilumed provides extensive wraparound services, including care coordination, patient outreach, and support for social determinants of health (SDoH) like transportation to appointments and meal delivery. This hands-on support for both providers and patients has yielded notable results, including achieving a 100% quality score from CMS and generating over $30 million in medical cost savings in 2022. The company has demonstrated rapid growth, expanding from serving 24,000 beneficiaries in four states in 2022 to over 56,000 across ten states in 2023.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Jupiter, United States
Employees
80
Open positions
4
Dealroom signal
29.7/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Business model
SaaS
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2021 $17M $66M Ascend Capital Partners · Ascend Partners ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

ilumed website traffic

Latest recorded traffic for ilumed is 3.3K monthly website visits, up 65% over the last three months. ilumed's team declined 13% over the past year.

Latest monthly visits3.3K 3-month web change+65% 1-year team growth-13%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Ascend Partners
  • Ascend Capital Partners

Other known investors1 additional known investor

  • CRG
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ilumed on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ilumed’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.